In addition to our proposed markers, KRT1, KRT2, and KRT10 were enriched in the C group among the stromal CDX2- population in our previous DVP experiment, consistent with the intensity increase observed in our larger adenoma cohort (Figure 5J). The gene discussed is KRT2; the disease is adenoma.